MNKD Q1 2025 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$78M+18.2% YoY

Gross Profit

$61M77.6% margin

Operating Income

$22M28.5% margin

Net Income

$13M16.8% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$410M

Total Liabilities

$469M

Stockholders' Equity

-$59M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$66M	+18.2%
Gross Profit	$61M	$48M	+27.6%
Operating Income	$22M	$17M	+33.3%
Net Income	$13M	$11M	+23.8%

Revenue Segments

Royalty

$30M38%

License And Service

$29M37%

Product

$19M24%